A Study to Assess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (FDC) Tablet in Human Immunodeficiency Virus (HIV)-1 Infected Children
Clinical trial NCT05197075 · COMPLETED
Trial details
- NCT number
- NCT05197075
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-03
- Primary completion
- 2022-09-23
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.